The new memorandum of understanding (MoU) aims to improve the clinical experience and knowledge of obstetric and gynaecological (ob-gyn) specialists at the hospital, while also raising public awareness of gynaecological health issues.
The MoU will run from 2023 to 2025, and will cover a number of initiatives. Bayer and NHOG will coordinate to develop and deliver new training content for healthcare materials under the arrangement. They will also run medical education programs and scientific seminars focused on the correct and safe use of modern contraceptives.
The initiatives will target the latest treatments and therapies for gynaecological conditions such as endometriosis, heavy menstrual bleeding, vaginal infections, and menopause management, as well as up-to-date guidelines on self-care and pregnancy nutrition. The partnership will also include collaborations and the exchange of knowledge with international ob-gyn organizations and experts.
Alongside this, the partnership will support online and offline disease awareness campaigns which aim to educate women about reproductive health and gynaecological issues, encouraging them to seek preventative care and early treatment. It is hoped that the collaboration will encourage women to take control of their own health and wellbeing.
“Educating both physicians and patients is essential for transforming healthcare quality, benefiting both patients and the medical community,” said Associate Professor Tran Danh Cuong, Director of the National Hospital of Obstetrics and Gynaecology. “Working together with Bayer Vietnam allows us to optimise our expertise in women’s health and broaden our outreach to improve public health literacy as well as the professional capacity of the healthcare workforce, not only at our hospital but also in satellite hospitals across the country.”
Elsewhere in Vietnam, Ho Chi Minh City’s FV Hospital celebrated the 20th anniversary of its opening on 9 April.